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Abstract
Branched polyethylenimine (BPEI) has an antimicrobial effect on bacteria. The killing mech-
anism of BPEI centers on its cationic properties. The mechanism of action against Gram-positive
bacteria is less understood but recent reports erroneously suggest that membrane depolarization
occurs. To the contrary, data from our laboratory suggests that BPEI binds to the anionic sites
provided by the biopolymer wall teichoic acid (WTA). To test the validity of this hypothesis, we
measure the amount BPEI binding to whole, intact, bacterial cells of Bacillus subtilis. Compara-
tive measurements are made with Bacillus subtilis bacteria that contain WTA and Bacillus subtilis
genetic mutants that lack WTA.
Using equilibrium dialysis, Bacillus subtilis bacteria were exposed to different solution concentra-
tions of BPEI. Removal of small aliquots from solution and subsequent assay with the ninhydrin
test were used to measure the amount of BPEI remaining in solution and the amount of BPEI
bound to the bacterial cell walls. These data were used to obtain the amount of bound vs. unbound
BPEI and determine the equilibrium constant. These data influence the understanding of BPEI
antimicrobial properties and impacts the development of antibiotics to treat human disease.
KEYWORDS: Branched polyethylenimine (BPEI); Bacillus subtilis; wall teichoic acid (WTA);
equilibrium dialysis
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ABSTRACT   
Branched polyethylenimine (BPEI) has an antimicrobial effect on bacteria. The killing 
mechanism of BPEI centers on its cationic properties. The mechanism of action against Gram-
positive bacteria is less understood but recent reports erroneously suggest that membrane 
depolarization occurs. To the contrary, data from our laboratory suggests that BPEI binds to the 
anionic sites provided by the biopolymer wall teichoic acid (WTA). To test the validity of this 
hypothesis, we measure the amount BPEI binding to whole, intact, bacterial cells of Bacillus 
subtilis. Comparative measurements are made with Bacillus subtilis bacteria that contain WTA 
and Bacillus subtilis genetic mutants that lack WTA. 
Using equilibrium dialysis, Bacillus subtilis bacteria were exposed to different solution 
concentrations of BPEI. Removal of small aliquots from solution and subsequent assay with the 
ninhydrin test were used to measure the amount of BPEI remaining in solution and the amount of 
BPEI bound to the bacterial cell walls. These data were used to obtain the amount of bound vs. 
unbound BPEI and determine the equilibrium constant. These data influence the understanding of 
BPEI antimicrobial properties and impacts the development of antibiotics to treat human disease.      
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